Onconova Therapeutic ONTX

$25.64 +24.65 (2,476.36%)

Valuation

Market cap
20,904,000
Revenue TTM
$230,000
Net income TTM
$-18,960,000
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
10,600
Avg volume
—
Day's range
$24.30 – $25.64
Shares out
21,003,000
Stochastic %K
—
Beta
1.38
Analysts
—
Price target
—

Price

Company profile

Under normal circumstances, the fund will invest at least 80% of the value of its net assets, plus any borrowings for investment purposes, in financial instruments (for example, swaps and futures) that, in the aggregate, provide leveraged exposure to the Underlying Security equal to approximately two times its daily performance. It is non-diversified.

Latest news

No headlines yet.